Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC73077 in Healthy Subjects

NCT05492630 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

138

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Nephropathy

Interventions

DRUG: HEC73077 tablets
DRUG: HEC73077 placebo tablets

Sponsor

Sunshine Lake Pharma Co., Ltd.